Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening

Br J Cancer. 2012 Feb 28;106(5):970-4. doi: 10.1038/bjc.2012.22. Epub 2012 Jan 31.

Abstract

Background: The SCREEN (Skin Cancer Research to provide Evidence for Effectiveness of Screening in Northern Germany) project involved population-wide skin cancer screening with whole-body examination by general physicians and dermatologists. It was conducted in the German state of Schleswig-Holstein (July 2003-June 2004), but not in the German state of Saarland.

Methods: The population-based registries of Schleswig-Holstein and Saarland provided data on melanoma incidence before, during, and after SCREEN to assess the association of skin cancer screening with incidence.

Results: Approximately 19% of the Schleswig-Holstein population participated in SCREEN (women: 27%, men: 10%). A total of 52% of all melanomas diagnosed during SCREEN in Schleswig-Holstein were detected as part of the project. Melanoma incidence increased during SCREEN (invasive melanoma in women: +8.9 per 100,000 (95% confidence intervals (CI): 6.1; 11.7); men: +4.0 per 100,000 (95% CI: 1.6; 6.4)) and decreased afterwards (women: -10.6 per 100,000 (95% CI: -13.3; -7.9); men: -4.1 per 100,000 (95% CI: -6.5; -1.7)). Similar changes were not observed in Saarland that had no such project. The differences between the two states were greatest among women, the group with the greater SCREEN participation.

Conclusion: The SCREEN project had a substantial impact on melanoma incidence. This is consistent with the impact of effective screening for other cancers.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Early Detection of Cancer*
  • Female
  • Germany / epidemiology
  • Humans
  • Incidence
  • Male
  • Mass Screening*
  • Melanoma / diagnosis*
  • Melanoma / epidemiology*
  • Middle Aged
  • National Health Programs
  • Patient Compliance
  • Sex Factors
  • Skin Neoplasms / diagnosis*
  • Skin Neoplasms / epidemiology*